The eyonis™ Lung Cancer Screening (LCS) REALITY data – What leading U.S. clinical pulmonology experts are saying

November 7, 2024

We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.

Register To Our Live Webcast

Data Protection Policies

Data Protection Policies

  •  

    Website Data Protection Policy

    Median Technologies places special emphasis on the privacy and security of your personal data. This policy thus describes how and why we process your personal data and informs you of your rights.

    Read more

  •  

    Personal data management of partners and contacts

    Median Technologies processes personal data for the following purposes: This represents a legitimate interest for Median Technologies in keeping its database of partners and contacts up to date. The data processed as part of this process is as follows: The data is intended for use by Median Technologies departments, each for its own purposes. Data […]

    Read more

  •  

    Information notice for investigator sites

    Median Technologies processes data to manage the participants in clinical trials. This includes managing contact lists, education, assessment and establishing statistics regarding the participants. The processing is based on the legitimate interests of Median Technologies in coordinating the clinical trials on behalf of its clients. The data were provided to us by the promotor of […]

    Read more